137 related articles for article (PubMed ID: 35533038)
1. Keratinocyte Carcinomas in Immunocompromised Patients Are Reduced After Administration of the Nonavalent Human Papillomavirus Vaccine.
Nichols A; Nahm W; Rabinovitz H; Ioannides T
J Drugs Dermatol; 2022 May; 21(5):526-528. PubMed ID: 35533038
[TBL] [Abstract][Full Text] [Related]
2. Association of Human Papillomavirus Vaccine With the Development of Keratinocyte Carcinomas.
Nichols AJ; Allen AH; Shareef S; Badiavas EV; Kirsner RS; Ioannides T
JAMA Dermatol; 2017 Jun; 153(6):571-574. PubMed ID: 28196178
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients.
Shamanin V; zur Hausen H; Lavergne D; Proby CM; Leigh IM; Neumann C; Hamm H; Goos M; Haustein UF; Jung EG; Plewig G; Wolff H; de Villiers EM
J Natl Cancer Inst; 1996 Jun; 88(12):802-11. PubMed ID: 8637046
[TBL] [Abstract][Full Text] [Related]
4. The role of HPV in keratinocyte skin cancer development: A systematic review.
Neagu N; Dianzani C; Venuti A; Bonin S; Voidăzan S; Zalaudek I; Conforti C
J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):40-46. PubMed ID: 36000380
[TBL] [Abstract][Full Text] [Related]
5. The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study.
Genders RE; Mazlom H; Michel A; Plasmeijer EI; Quint KD; Pawlita M; van der Meijden E; Waterboer T; de Fijter H; Claas FH; Wolterbeek R; Feltkamp MCW; Bouwes Bavinck JN
J Invest Dermatol; 2015 May; 135(5):1275-1282. PubMed ID: 25347116
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals.
Harwood CA; Surentheran T; McGregor JM; Spink PJ; Leigh IM; Breuer J; Proby CM
J Med Virol; 2000 Jul; 61(3):289-97. PubMed ID: 10861635
[TBL] [Abstract][Full Text] [Related]
7. E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients.
Dang C; Koehler A; Forschner T; Sehr P; Michael K; Pawlita M; Stockfleth E; Nindl I
Br J Dermatol; 2006 Jul; 155(1):129-36. PubMed ID: 16792764
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series.
Harwood CA; Proby CM; McGregor JM; Sheaff MT; Leigh IM; Cerio R
J Am Acad Dermatol; 2006 Feb; 54(2):290-300. PubMed ID: 16443060
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore.
Phua LC; Choi HCW; Wu J; Jit M; Low J; Ng K; Pearce F; Hall C; Abdul Aziz MI
Vaccine; 2021 Apr; 39(16):2255-2263. PubMed ID: 33744050
[TBL] [Abstract][Full Text] [Related]
10. Human Beta-papillomavirus infection and keratinocyte carcinomas.
Quint KD; Genders RE; de Koning MN; Borgogna C; Gariglio M; Bouwes Bavinck JN; Doorbar J; Feltkamp MC
J Pathol; 2015 Jan; 235(2):342-54. PubMed ID: 25131163
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers Found in the Tumor Interstitial Fluid may Help Explain the Differential Behavior Among Keratinocyte Carcinomas.
Matas-Nadal C; Bech-Serra JJ; Gatius S; Gomez X; Ribes-Santolaria M; Guasch-Vallés M; Pedraza N; Casanova JM; de la Torre Gómez C; Garí E; Aguayo-Ortiz RS
Mol Cell Proteomics; 2023 Jun; 22(6):100547. PubMed ID: 37059366
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin.
Karagas MR; Nelson HH; Sehr P; Waterboer T; Stukel TA; Andrew A; Green AC; Bavinck JN; Perry A; Spencer S; Rees JR; Mott LA; Pawlita M
J Natl Cancer Inst; 2006 Mar; 98(6):389-95. PubMed ID: 16537831
[TBL] [Abstract][Full Text] [Related]
13. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
14. Combined Systemic and Intratumoral Administration of Human Papillomavirus Vaccine to Treat Multiple Cutaneous Basaloid Squamous Cell Carcinomas.
Nichols AJ; Gonzalez A; Clark ES; Khan WN; Rosen AC; Guzman W; Rabinovitz H; Badiavas EV; Kirsner RS; Ioannides T
JAMA Dermatol; 2018 Aug; 154(8):927-930. PubMed ID: 29971321
[TBL] [Abstract][Full Text] [Related]
15. Clinical and economic impact of school-based nonavalent human papillomavirus vaccine on women in Singapore: a transmission dynamic mathematical model analysis.
Tay SK; Hsu TY; Pavelyev A; Walia A; Kulkarni AS
BJOG; 2018 Mar; 125(4):478-486. PubMed ID: 29266694
[TBL] [Abstract][Full Text] [Related]
16. Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine.
Drolet M; Laprise JF; Boily MC; Franco EL; Brisson M
Int J Cancer; 2014 May; 134(9):2264-8. PubMed ID: 24174175
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccination update: Nonavalent vaccine and the two-dose schedule.
Brotherton JM
Aust J Gen Pract; 2018 Jul; 47(7):417-421. PubMed ID: 30114867
[TBL] [Abstract][Full Text] [Related]
18. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
[TBL] [Abstract][Full Text] [Related]
19. Risk of subsequent keratinocyte carcinomas after a first diagnosis in Tasmania, Australia.
Ragaini BS; Blizzard L; Venn A
Australas J Dermatol; 2023 Feb; 64(1):108-117. PubMed ID: 36269635
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin.
Nahm W; Nichols A; Rapoport E; Kirsner R; Badiavas E; Wyant W; Arthur A; Shen J
J Drugs Dermatol; 2023 May; 22(5):486-490. PubMed ID: 37133482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
